Non-profit website: free to use. No fees from patients, hospitals or doctors. Not an agency. · Free · Not an agencyAbout this site
Hematology · Peking University People's Hospital · Beijing

Dr. Huang Xiaojun黄晓军

Chief Physician · Professor

Summary compiled from public information, updated 18 Nov 2026. It has not been checked against the hospital website yet. Confirm details with the hospital before you travel.

HX

Professional overview

Huang Xiaojun is a Chief Physician and Professor at Peking University People's Hospital, specializing in hematologic diseases and complications following hematopoietic stem cell transplantation (HSCT), including graft-versus-host disease (GVHD), infection, and relapse.

SpecialtyHematology
Clinical titleChief Physician
Academic rolesProfessor, Doctoral Supervisor
DepartmentInstitute of Hematology
HospitalPeking University People's Hospital
CityBeijing
Hospital roleDirector of the Institute of Hematology

Areas of focus

Hematologic diseasesSpecializes in hematologic diseases and complications following hematopoietic stem cell transplantation (HSCT), including graft-versus-host disease (GVHD), infection, and relapse.
Hematopoietic stem cell transplantationDeveloped the internationally recognized non-ex vivo T-cell-depleted haploidentical HSCT system — the 'Beijing Protocol' — based on granulocyte colony-stimulating factor-induced immune tolerance.

Background

  • 1982–1987Bachelor of Medicine, Sun Yat-sen University Medical College
  • 1987–1992PhD, Beijing Medical University
  • 1992–1994Attending Physician, Institute of Hematology, Peking University People's Hospital
  • 1994–1998Associate Chief Physician, Institute of Hematology, Peking University People's Hospital
  • 1997–1998Visiting Scholar, Albert Einstein College of Medicine Cancer Research Center
  • 1998–2001Associate Professor, Institute of Hematology, Peking University People's Hospital
  • 2001–2002Chief Physician, Institute of Hematology, Peking University People's Hospital
  • 2002–presentProfessor and Director, Institute of Hematology, Peking University People's Hospital

Experience & recognition

  • Led development of the 'Beijing Protocol' — an internationally recognized non-ex vivo T-cell-depleted haploidentical HSCT system
  • The 'Beijing Protocol' is included in authoritative international textbooks including Thomas' Hematopoietic Cell Transplantation and Clinical Transplantation
  • Published over 270 SCI papers as first or corresponding author, including in New England Journal of Medicine (2 letters), Journal of Clinical Oncology (3), Blood (11), and Leukemia (6)
  • Led formulation of 10 clinical guidelines for hematologic diseases in China
  • Recipient of the State Council Special Allowance
  • Changjiang Scholar (Ministry of Education)
  • National Science Fund for Distinguished Young Scholars

Professional roles

  • Chair, Hematology Society, Chinese Medical Association (CMA)
  • President, Asia-Pacific Society for Cell Therapy
  • Chair, Executive Committee, Asia-Pacific Hematology Alliance
  • Former President, Hematology Branch, Chinese Medical Doctor Association (CMDA)
  • Member, International Council, American Society of Hematology (ASH)
  • Editor-in-Chief, Chinese Journal of Hematology
  • Deputy Editor, British Journal of Haematology
  • Deputy Editor, Journal of Hematology & Oncology

Frequently asked questions

What does Dr. Huang Xiaojun specialize in?

Specializes in hematologic diseases and complications following hematopoietic stem cell transplantation (HSCT), including graft-versus-host disease (GVHD), infection, and relapse; developed the 'Beijing Protocol' — a non-ex vivo T-cell-depleted haploidentical HSCT system.

Which hospital and department is Dr. Huang Xiaojun in?

At Peking University People's Hospital, Institute of Hematology

Sources

Dr. Huang Xiaojun has not reviewed this page.